Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.12.7613

Helicobacter pylori Infection and the Risk of Colorectal Adenoma and Adenocarcinoma: an Updated Meta-analysis of Different Testing Methods  

Chen, Yao-Sheng (Department of Gastroenterology, Yangzhou NO.1 People's Hospital)
Xu, Song-Xin (Department of Gastroenterology, Yangzhou NO.1 People's Hospital)
Ding, Yan-Bing (Department of Gastroenterology, Yangzhou NO.1 People's Hospital)
Huang, Xin-En (Department of Chemotherapy, the Affiliated Jiangsu Cancer Hospital of Nanjing Medical University and Jiangsu Institute of Cancer Research)
Deng, Bin (Department of Gastroenterology, Yangzhou NO.1 People's Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.12, 2013 , pp. 7613-7619 More about this Journal
Abstract
Background and Aims: Helicobacter pylori infection may be associated with an increased risk of colorectal carcinoma. However, as most studies on this subject were relatively small in size and differed at least partially in their designs, their results remain controversial. In this study, we aimed to carry out a meta-analysis to evaluate the potential association of H. pylori infection with colorectal adenoma and adenocarcinoma risk, covering all of the different testing methods. Methods: We conducted a search in PubMed, Medline, EBSCO, High Wire Press, OVID, and EMBASE covering all published papers up to March 2013. According to the established inclusion criteria, essential data were then extracted from the included studies and further analyzed by a systematic meta-analysis. Odds ratios were employed to evaluate the relationship between H. pylori infection and the risk of colorectal neoplasms. Results: Twenty-two studies were included, and the odds ratio for the association between H. pylori infection and colorectal cancer was 1.49 (95% confidence interval 1.30-1.72). No statistically significant heterogeneity was observed. Publication bias was ruled out. Conclusion: The pooled data suggest H. pylori infection indeed increases the risk of colorectal adenoma and adenocarcinoma.
Keywords
Helicobacter pylori; colorectal adenoma; adenocarcinoma; risk; meta-analysis;
Citations & Related Records
Times Cited By KSCI : 18  (Citation Analysis)
연도 인용수 순위
1 Shmuely H, Passaro D, Figer A, et al (2001). Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol, 96, 3406-10.   DOI
2 Shu J, Li CG, Liu YC, et al (2012). Comparison of Serum Tumor Associated Material (TAM) with Conventional Biomarkers in Cancer Patients. Asian Pac J Cancer Prev, 13, 2399-403.   과학기술학회마을   DOI   ScienceOn
3 Siddheshwar RK, Muhammad KB, Gray JC, Kelly SB (2001). Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma. Am J Gastroenterol, 96, 84-8.   DOI
4 Sobhani I, Lehy T, Laurent-Puig P, et al (1993). Chronic endogenous hypergastrinemiain humans: evidence for a mitogenic effect on the colonic mucosa. Gastroenterology, 105, 2-30.
5 Sonnenberg A, Genta RM (2013). Helicobacter pylori is a risk factor for colonic neoplasms. Am J Gastroenterol, 108, 208-15.   DOI   ScienceOn
6 Strofilas A, Lagoudianakis EE, Seretis C, et al (2012). Association of Helicobacter pylori infection and colon cancer. J Clin Med Res, 4, 172-6.
7 Sun MQ, Meng AF, Huang XE, et al (2013). Comparison of psychological influence on breast cancer patients between breast-conserving surgery and modified radical mastectomy. Asian Pac J Cancer Prev, 14, 149-52.   과학기술학회마을   DOI   ScienceOn
8 Talley NJ, Zinsmeister AR, Weaver A, et al (1991). Gastric adenocarcinoma andHelicobacter pylori infection. J Natl Cancer Inst, 83, 1734-9.   DOI
9 Tenesa A, Dunlop MG (2009). New insights into the aetiology of colorectalcancer from genome-wide association studies. Nat Rev Genet, 10, 353-8.
10 Thorburn CM, Friedman GD, Dickinson CJ, et al (1998). Gastrin and colorectal cancer:a prospective study. Gastroenterology, 115, 275-80.   DOI   ScienceOn
11 Wu IC, Wu DC, Yu FJ, et al (2009). Association between Helicobacter pylori seropositivity anddigestive tract cancers. World J Gastroenterol, 15, 5465-71.   DOI
12 Xu HX, Huang XE, Li Y, et al (2011). A clinical study on safety and efficacy of Aidi injection combined with chemotherapy. Asian Pac J Cancer Prev, 12, 2233-6.
13 Xu HX, Huang XE, Qian ZY, et al (2011). Clinical observation of Endostar combined with chemotherapy in advanced colorectal cancer patients. Asian Pac J Cancer Prev, 12, 3087-90.
14 Xu HX, Huang XE, Qian ZY, et al (2011). Clinical observation of Endostar(R) combined with chemotherapy in advanced colorectal cancer patients. Asian Pac J Cancer Prev, 12 (11):3087-90.
15 Xu JW, Li CG, Huang XE, et al (2011). Ubenimex capsule improves general performance and chemotherapy related toxicity in advanced lung adenocarcinoma cases. Asian Pac J Cancer Prev, 12, 985-7.
16 Xu T, Xu ZC, Zou Q, Yu B, Huang XE (2012). P53 Arg72Pro polymorphism and bladder cancer risk--meta-analysis evidence for a link in Asians but not Caucasians. Asian Pac J Cancer Prev, 13, 2349-54.   과학기술학회마을   DOI   ScienceOn
17 Xu X, Wang L, Xu HQ, Huang XE, et al (2013). Clinical comparison between paclitaxel liposome (Lipusu(R)) and paclitaxel for treatment of patients with metastatic gastric cancer. Asian Pac J Cancer Prev, 14, 2591-4.   과학기술학회마을   DOI   ScienceOn
18 Yan PW, Huang XE, Jiang Y, et al (2010). A clinical comparison on safety and efficacy of Paclitaxel/Epirubicin (NE) with Fluorouracil/Epirubicin/Cyclophosphamide (FEC) as postoperative adjuvant chemotherapy in breast cancer. Asian Pac J Cancer Prev, 11, 1115-8.
19 Yan PW, Huang XE, Jiang Y, et al (2010). A clinical comparison on safety and efficacy of Paclitaxel/Epirubicin (NE) with Fluorouracil/Epirubicin/Cyclophosphamide (FEC) as postoperative adjuvant chemotherapy in breast cancer. Asian Pac J Cancer Prev, 11, 1115-8.
20 Yan PW, Huang XE, Yan F, et al (2011). Influence of MDR1 gene codon 3435 polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancer. Asian Pac J Cancer Prev, 12, 2291-4.
21 Yin HT, Zhang DG, Wu XL, Huang XE, Chen G (2013). In vivo evaluation of curcumin-loaded nanoparticles in a A549 xenograft mice model. Asian Pac J Cancer Prev, 14, 409-12.   과학기술학회마을   DOI   ScienceOn
22 Yu DS, Huang XE, Zhou JN, et al (2012). Comparative study on the value of anal preserving surgery for aged people with low rectal carcinoma in Jiangsu, China. Asian Pac J Cancer Prev, 13, 2339-40.   과학기술학회마을   DOI   ScienceOn
23 Zhan YP, Huang XE, Cao J, Clinical study on safety and efficacy of Qinin (cantharidin sodium) injection combined with chemotherapy in treating patients with gastric cancer. Asian Pac J Cancer Prev, 13, 4773-6.   과학기술학회마을   DOI   ScienceOn
24 Zhan YP, Huang XE, Cao J (2012). Clinical safety and efficacy of Kanglaite (Coix Seed Oil) injection combined with chemotherapy in treating patients with gastric cancer. Asian Pac J Cancer Prev, 13, 5319-21.   과학기술학회마을   DOI   ScienceOn
25 Zhang LQ, Huang XE, Wang J (2011). The cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a metaanalysis of 20 populations. Asian Pac J Cancer Prev, 12, 81-5.
26 Zhang XZ, Huang XE, Xu YL, et al (2012). A phase II study on Voriconazole in treating Chinese patients with malignant hematological disorder and invasive aspergillosis. Asian Pac J Cancer Prev, 13, 2415-8.   DOI   ScienceOn
27 ZhangYan, Michael Hoffmeister, Melanie N. Weck, et al (2012). Helicobacter pylori infection and colorectal cancer risk: evidence from a large population-based case-control study in Germany. Am J Epidemiol, 175, 441-50.   DOI   ScienceOn
28 Zhou JN, Huang XE, Ye Z, et al (2009). Weekly paclitaxel/Docetaxel combined with a paltinum in the treatment of advanced non-samll cell lung cancer: a study on efficacy, safety and pre-medication. Asian Pac J Cancer Prev, 10, 1147-50.
29 Zhu Y, Wu H, Wang PP, et al (2013). Dietarypatterns and colorectalcancer recurrence andsurvival: a cohort study. BMJ Open, 3, e002270.   DOI
30 Abbass K, Gul W, Beck G, Markert R, Akram S (2011). Association of Helicobacter pylori infection with the development of colorectal polyps and colorectal carcinoma. South Med J, 104, 473-6.   DOI   ScienceOn
31 Ai Machida-Montani, Shizuka Sasazuki, Manami Inoue, et al (2007). atrophic gastritis, helicobacter pylori, and colorectal cancerrisk: a case-control study. Helicobacter, 12, 328-32.   DOI   ScienceOn
32 Beales IL, Crabtree JE, Scunes D, et al (1996). Antibodies to CagA protein are associatedwith gastric atrophy in Helicobacter pylori infection. Eur J Gastroenterol Hepatol, 8, 645-9.
33 Breuer-Katschinski B, Nemes K, Marr A, et al (1999). Helicobacter pylori and the risk of colonic adenomas. Colorectal Adenoma Study Group. Digestion, 60, 210-5.   DOI   ScienceOn
34 Bulajic M, Stimec B, Jesenofsky R, et al (2007). Helicobacter pylori in colorectal carcinomatissue. Cancer Epidemiol Biomarkers Prev, 16, 631-3.   DOI   ScienceOn
35 Buso AG, Rocha HL, Diogo DM, Diogo PM, Diogo-Filho A (2009). Seroprevalence of Helicobacter pylori in patients with colon adenomas in a Brazilian university hospital. Arq Gastroenterol, 46, 97-101.   DOI   ScienceOn
36 Chen TS, Chang FY, Chen PC, et al (2003). Simplified 13C-urea breath test with a newinfrared spectrometer for diagnosis of Helicobacter pylori infection. J Gastroenterol Hepatol, 18, 1237-43.   DOI   ScienceOn
37 De Luca A, Iaquinto G (2004). Helicobacter pylori and gastric diseases: a dangerousassociation. Cancer Lett, 213, 1-10.   DOI   ScienceOn
38 Deng QQ, Huang XE, Ye LH, et al (2013). Phase II trial of Loubo(R) (Lobaplatin) and pemetrexed for patients with metastatic breast cancer not responding to anthracycline or taxanes. Asian Pac J Cancer Prev, 14, 413-7.   과학기술학회마을   DOI   ScienceOn
39 Engle SJ, Ormsby I, Pawlowski S, et al (2002). Elimination of colon cancer in germ-freetransforming growth factor beta1-deficient mice. Cancer Res, 62, 6362-6.
40 Erdman SE, Poutahidis T, Tomczak M, et al (2003). CD41 CD251 regulatory T lymphocytesinhibit microbially induced colon cancer in Rag2-deficient mice. Am JPathol, 162, 691-702.
41 Fearon ER, Vogelstein B (1990). A genetic model for colorectal tumorigenesis. Cell, 61, 759-67.   DOI   ScienceOn
42 Fireman Z, Trost L, Kopelman Y, Segal A, Sternberg A (2000). Helicobacter pylori: seroprevalence and colorectal cancer. Isr Med Assoc J, 2, 6-9.
43 Fujimori S, Kishida T, Kobayashi T, et al (2005). Helicobacter pylori infection increases the risk of colorectal adenomaand adenocarcinoma, especially in women. J Gastroenterol, 40, 887-93.   DOI
44 Gao LL, Huang XE, Zhang Q, et al (2011). A Cisplatin and vinorelbine (NP) regimen as a postoperative adjuvant chemotherapy for completely resected breast cancers in China: final results of a phase II clinical trial. Asian Pac J Cancer Prev, 12, 77-80.
45 Georgopoulos SD, Polymeros D, Triantafyllou K, et al (2006). Hypergastrinemia is associatedwith increased risk of distal colon adenomas. Digestion, 74, 42-6.   DOI   ScienceOn
46 Gong P, Huang XE, Chen CY, et al (2012). Comparison on complications of peripherally inserted central catheters by ultrasound guide or conventional method in cancer patients. Asian Pac J Cancer Prev, 13, 1873-5.   DOI   ScienceOn
47 Grahn N, Hmani-Aifa M, Fransen K, et al (2005). Molecular identification of HelicobacterDNA present in human colorectal adenocarcinomas by 16s rDNA PCRamplification andpyrosequencing analysis. J Med Microbiol, 54, 1031-5.   DOI   ScienceOn
48 Gu M, Li SY, Huang XE, et al (2013). A phase II study on continuous infusional paclitaxel and 5-Fu as first-line chemotherapy for patients with advanced esophageal cancer. Asian Pac J Cancer Prev, 13, 5587-91.   과학기술학회마을   DOI   ScienceOn
49 Hartwich A, Konturek SJ, Pierzchalski P, et al (2001). Helicobacter pyloriinfection, gastrin, cyclooxygenase-2, and apoptosis in colorectal cancer. Int J Colorectal Dis, 16, 202-10.   DOI
50 Huang XE, Li CG, Li Y, et al (2011). Weekly TP regimen as a postoperative adjuvant chemotherapy for completely resected breast cancer in China: final result of a phase II trial. Asian Pac J Cancer Prev, 12, 2797-800.
51 Huang XE, Wei GL, Huo JG, et al (2013). Intrapleural or intraperitoneal lobaplatin for treatment of patients with malignant pleural effusion or ascites. Asian Pac J Cancer Prev, 14, 2611-4.   과학기술학회마을   DOI   ScienceOn
52 Inoue I, Mukoubayashi C, Yoshimura N, et al (2011). Elevated risk of colorectal adenoma with Helicobacter pylori-related chronic gastritis: apopulation-basedcase-control study. Int J Cancer, 129, 2704-11.   DOI   ScienceOn
53 Jemal A, Center MM, Ward E, Thun MJ (2009). Cancer occurrence.Methods Mol Biol, 471, 3-29.   DOI   ScienceOn
54 Jiang Y, Huang XE, Yan PW, et al (2010). Validation of treatment efficacy of a computer-assisted program for breast cancer patients receiving postoperative adjuvant chemotherapy. Asian Pac J Cancer Prev, 11, 1059-62.
55 Jones M, Helliwell P, Pritchard C, et al (2007). Helicobacter pylori in colorectalneoplasms: is there an aetiological relationship? World J Surg Oncol, 5, 51.   DOI   ScienceOn
56 Korkmaz H, Kesli R, Karabagli P, Terzi Y (2013). Comparison of the diagnostic accuracy of five different stool antigen tests for the diagnosis of Helicobacter pylori infection. Helicobacter, 18, 384-91.   DOI   ScienceOn
57 Li CG, Huang XE, Li Y, et al (2011). Clinical observations on safety and efficacy of OxyContin administered by rectal route in treating cancer related pain. Asian Pac J Cancer Prev, 12, 2477-8.
58 Li CG, Huang XE, Xu L, et al (2012). Clinical application of serum tumor associated material (TAM) from non-small cell lung cancer patients. Asian Pac J Cancer Prev, 13, 301-4.   과학기술학회마을   DOI   ScienceOn
59 Li CG, Huang XE, Li Y, et al (2011). Phase II trial of irinotecan plus nedaplatin (INP) in treating patients with extensive stage small cell lung cancer. Asian Pac J Cancer Prev, 12, 487-90.
60 Limburg PJ, Stolzenberg-Solomon RZ, Colbert LH, et al (2002). Helicobacter pylori seropositivity and colorectal cancer risk: a prospective study of male smokers.Cancer Epidemiol Biomarkers Prev, 11, 1095-9.
61 Li Y, Yan PW, Huang XE, et al (2011). MDR1 gene C3435T polymorphism is associated with clinical outcomes in gastric cancer patients treated with postoperative adjuvant chemotherapy. Asian Pac J Cancer Prev, 12, 2405-9.
62 Liou JM, Lin JW, Huang SP, et al (2006). Helicobacter pylori infection is not associatedwith increased risk of colorectal polyps in Taiwanese. Int J Cancer, 119, 1999-2000.   DOI   ScienceOn
63 Liu J, Huang XE, Tian GY, et al (2013). Phase II study on safety and efficacy of Yadanzi(R) (Javanica oil emulsion injection) combined with chemotherapy for patients with gastric cancer. Asian Pac J Cancer Prev, 14, 2009-12.   과학기술학회마을   DOI   ScienceOn
64 Liu W, Li SY, Huang XE, et al (2012). Inhibition of tumor growth in vitro by a combination of extracts from rosa roxburghii tratt and fagopyrum cymosum. Asian Pac J Cancer Prev, 13, 2409-14.   과학기술학회마을   DOI   ScienceOn
65 Liu YC, Zhou SB, Gao F, et al (2013). Chemotherapy and late course three dimensional conformal radiotherapy for treatment of patients with stage III non- small cell lung cancer. Asian Pac J Cancer Prev, 14, 2663-5.   과학기술학회마을   DOI   ScienceOn
66 Lochhead P, El-Omar EM (2007). Helicobacter pylori infection and gastric cancer. BestPract Res Clin Gastroenterol, 21, 281-97.   DOI   ScienceOn
67 Lu YY, Huang XE, Cao J, et al (2013). Phase II study on Javanica oil emulsion injection (Yadanzi(R)) combined with chemotherapy in treating patients with advanced lung adenocarcinoma. Asian Pac J Cancer Prev, 14, 4791-4.   과학기술학회마을   DOI   ScienceOn
68 Maeda S, Mentis AF (2007). Pathogenesis of Helicobacter pylori infection. Helicobacter, 12, 10-4.   DOI   ScienceOn
69 Meucci G, Tatarella M, Vecchi M, et al (1997). High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas. J Clin Gastroenterol, 25, 605-7.   DOI   ScienceOn
70 Mizuno S, Morita Y, Inui T, et al (2005). Helicobacter pylori infection is associated with colon adenomatous polyps detectedby high-resolution colonoscopy. Int J Cancer, 117, 1058-9.   DOI   ScienceOn
71 Moss SF, Neugut AI, Garbowski GC, et al (1995). Helicobacter pylori seroprevalence and colorectalneoplasia: evidence against an association. J Natl Cancer Inst, 87, 762-33   DOI   ScienceOn
72 Mulholland G, Ardill JE, Fillmore D, et al (1993). Helicobacter pylori related hypergastrinaemiais the result of a selective increase in gastrin 17. Gut, 34, 757-61.   DOI
73 Penman ID, el-Omar E, Ardill JE, et al (1994). Plasma gastrin concentrations arenormal in patients with colorectal neoplasia and unalteredfollowing tumor resection. Gastroenterology, 106, 1263-70.   DOI